Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia [NA]

View source ↗

Summary

HEALTH4CLL2 is a randomized waitlist-controlled trial evaluating behavioral interventions for patients with chronic lymphocytic leukemia. The study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Lymphocytic Leukemia | NA | Status: ACTIVE_NOT_RECRUITING